Kardigan, Inc.

NASDAQ: KARD · Healthcare · Biotechnology

PublicHQ Princeton, NJ · MercerReports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 54

v0.1 · 5/100 weight · pillars only

↑ market scale, workforce scale · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

231

Market cap

$2.2B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Kardigan, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Harmony Biosciences Holdings, Inc.76B+Pediatrix Medical Group, Inc.76B+Agios Pharmaceuticals, Inc.70B Ocular Therapeutix, Inc.62C

Neighbors

Mercer →

Bristol-Myers Squibb Company$48.2B85A Essential Properties Realty Trust, Inc.$561.2M69B Clearway Energy, Inc.$1.4B56C Miami International Holdings, Inc. $1.4B43D UroGen Pharma Ltd.$109.8M54D Integra LifeSciences Holdings Corporation$1.6B67B

Key facts

CEOTassos Gianakakos

SectorHealthcare

IndustryBiotechnology

HeadquartersPrinceton, NJ

ExchangeNASDAQ: KARD

Employees231

IPO date2026-06-18

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.